Estimated Public Health Impact of the Recombinant Zoster Vaccine

Objective: To investigate the potential public health impact of adult herpes zoster (HZ) vaccination with the adjuvanted recombinant zoster vaccine (RZV) in the United States in the first 15 years after launch. Methods: We used a publicly available model accounting for national population characteri...

Full description

Bibliographic Details
Main Authors: Brandon J. Patterson, PharmD, PhD, Philip O. Buck, PhD, MPH, Desmond Curran, PhD, Desirée Van Oorschot, MSc, Justin Carrico, BS, William L. Herring, PhD, Yuanhui Zhang, PhD, Jeffrey J. Stoddard, MD
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454821000539